Skip to main content
BioArctic AB (publ) (STO:BIOA.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
299.00
+0.20 (0.07%)
Mar 9, 2026, 4:31 PM CET

BioArctic AB Revenue

In the year 2025, BioArctic AB had annual revenue of 2.00B SEK with 676.80% growth. BioArctic AB had revenue of 184.04M in the quarter ending December 31, 2025, with 81.79% growth.

Revenue
2.00B
Revenue Growth
+676.80%
P/S Ratio
13.30
Revenue / Employee
15.26M
Employees
131
Market Cap
26.58B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.00B1.74B676.80%
Dec 31, 2024257.35M-358.64M-58.22%
Dec 31, 2023616.00M386.56M168.49%
Dec 31, 2022229.43M203.77M794.02%
Dec 31, 202125.66M-39.54M-60.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Camurus AB 2.27B
Hansa Biopharma AB 222.27M
Flerie AB 2.80M
Vicore Pharma Holding AB 3.82M
Egetis Therapeutics AB 62.40M
Diamyd Medical AB 349.00K
Saniona AB 434.40M
BioInvent International AB 226.50M
Revenue Rankings

BioArctic AB News

More News